This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Mr. Imroz Ghangas
Senior Director Business Development at Asimov
Speaker

Profile

Imroz Ghangas is currently a Senior Director of Business Development at Asimov, where he leads initiatives in the Americas and Asia, focused on advancing synthetic biology solutions. With over 20 years of biotechnology industry experience, Imroz has a proven track record of fostering technical collaborations between therapeutic developers and technology innovators. He brings deep expertise across the bioprocess workflow, including cell line engineering, upstream and downstream process development, and manufacturing. Imroz is passionate about strengthening the connections between therapeutic design, process development, and manufacturing to drive improvements in therapeutic outcomes. Prior to joining Asimov, he held scientific and commercial roles at Amgen, Cytiva, and Samsung Biologics, where he played a key role in developing and implementing innovative solutions for biopharma companies. Imroz holds an MBA from UC Davis and a Bachelor’s degree in Biochemistry from Penn State University, and he remains committed to leveraging cutting-edge technologies to drive impact in the biopharmaceutical space.

Agenda Sessions

  • Integrating Synthetic Biology and Computer-aided Design to Advance Biologics Production in CHO Cells

    1:45pm